Evercore ISI set a $50.00 price target on Moderna in a research note on Friday, February 14th. The Goldman Sachs Group downgraded Moderna from a “buy” rating to a “neutral” rating and ...

Mutual of America Capital Management LLC trimmed its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 2.6% during the ...

With the post-election bump erased from stocks, souring sentiment has been especially pronounced among hedge funds. Fund managers net sold US equities for 10 of the last 11 weeks, which pushed the US ...

3 analysts have bearish recommendations on Moderna, while 2 analysts have bullish ratings. The street high price target from Goldman Sachs is $99.0, while the street low from B of A Securities is ...

Consistent in their evaluation, an analyst from UBS keeps a Buy rating on Moderna with a target price of $78. * In a cautious move, an analyst from Goldman Sachs downgraded its rating to Neutral ...

Each of the 15 most innovative companies in advertising and marketing built strong campaigns using cultural cachet.

The second group, so-called "Constrained Losers," are those hard-to-short stocks that have lost the most over the trailing year. The professors found that these stocks also lag the market, but for a ...

Pharmaceutical giant Moderna Inc. (NASDAQ:MRNA) lost 7.28 percent of its value on Monday to end the day at $36.55 apiece as investors continued to sell off positions following Goldman Sachs ...

The updated model from Goldman Sachs, reflecting these considerations ... which could potentially raise $3.1 billion. Meanwhile, Moderna (NASDAQ:MRNA) saw a rise in investor confidence following ...

All the latest breaking news on stock market. Browse ibtimes archives of photos, videos and articles on stock market.